FFAR3 and hepatocellular carcinoma: In contrast, a role for FFAR3 in the anti-proliferative synergistic effect obtained with propionate and cisplatin on human hepatocellular carcinoma cells has been reported [36] and a recent study reveals that the activation of FFAR3 by SCFAs inhibit bovine epithelial cells proliferation [37].